Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue

Head and Neck

Volumn 33, Issue 11, 2011, Pages 1622-1627

  Harris, Stephen L ^a   Thorne, Leigh B ^a,b   Seaman, William T ^b   Neil Hayes, D ^a,b   Couch, Marion E ^a,b   Kimple, Randall J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

head and neck cancer; HPV; p16; tongue; young

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PROTEIN P53; TUMOR MARKER; VIRUS DNA;

ADULT; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; WART VIRUS; ADOLESCENT; ANALYSIS OF VARIANCE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; NONPARAMETRIC TEST; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEROLOGY; SURVIVAL; TONGUE TUMOR; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEROLOGIC TESTS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80054042271     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21650     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. Shiboski C, Schmidt BL, Jordan R,. Tongue and tonsil carcinoma. Cancer. 2005; 103: 1843-1849.
3. Schantz SP, Yu G-P,. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 268-274. (Pubitemid 34218579)
4. Curado M, Hashibe M,. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 2009; 21: 194-200.
5. Fakhry C, Gillison ML,. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24: 2606-2611. (Pubitemid 46622080)
6. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008: 261-269. (Pubitemid 351480538)
7. Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009; 140: 228-234.
8. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-753. (Pubitemid 36237483)
9. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
10. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J,. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
11. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747. (Pubitemid 46622040)
12. Shah NG, Trivedi TI, Tankshali RA, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009; 31: 1544-1556.
13. Weinberger PM, Yu Z, Haffty BG, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 2004; 10: 5684-5691. (Pubitemid 39180943)
14. Reimers N, Kasper HU, Klussmann JP,. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738. (Pubitemid 46399359)
15. Harris S, Kimple RJ, Hayes DN, Couch ME, Rosenman JG,. Never-smokers, never-drinkers: a unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck 2010; 32: 499-503.
16. Andrews E, Shores C, Hayes DN, et al. Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couples. J Infect Dis 2009; 200: 882-887.
17. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738. (Pubitemid 46399359)
18. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747. (Pubitemid 46622040)
19. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-753. (Pubitemid 36237483)
20. Singhi A, Westra W,. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010; 116: 2166-2173.
21. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med 2006; 354: 567-578. (Pubitemid 43209104)
22. Singh B, Pfister DG,. Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge? J Clin Oncol 2008; 26: 3114-3116.
23. Makitie A, MacMillan C, Ho J, et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res 2003; 9: 2177-2184. (Pubitemid 36687641)
24. Gillison ML, Harris J, Westra W, et al. Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. J Clin Oncol (Meeting Abstracts) 2009; 27 (Suppl 15): 6003.
25. Calzolari A, Chiarelli I, Bianchi S, et al. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol 1997; 107: 7-11. (Pubitemid 27104629)
26. Psyrri A, Yu Z, Weinberger PM, et al. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 2005; 11: 5856-5862. (Pubitemid 41170313)
27. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 2007; 43: 193-198. (Pubitemid 46176708)
28. Eriksen JG, Steiniche T, Askaa J, Alsner J, Overgaard J,. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2004; 58: 561-566. (Pubitemid 38142484)
29. Kim SH, Juhnn YS, Kang S, et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt. Cell Mol Life Sci 2006; 63: 930-938. (Pubitemid 43724080)